Cargando…

Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States

INTRODUCTION: Multiple myeloma (MM) is the second most frequent hematologic malignancy after lymphoma, contributing to approximately 10% of all hematologic malignancies. The prognosis of patients with MM is impacted by the heterogeneity of the disease, with worse outcomes reported in patients classi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Megan S., Naeger, Sarah, Singh, Erin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140164/ https://www.ncbi.nlm.nih.gov/pubmed/33728584 http://dx.doi.org/10.1007/s40487-021-00146-4

Ejemplares similares

Real-world renal function among patients with multiple myeloma in the United States
por: Mikhael, Joseph, et al.
Publicado: (2021)

Real‐world multiple myeloma front‐line treatment and outcomes by transplant in the United States
por: Richter, Joshua, et al.
Publicado: (2023)

Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States
por: Fonseca, Rafael, et al.
Publicado: (2023)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Development of a real-world database for asthma and COPD: The SingHealth-Duke-NUS-GSK COPD and Asthma Real-World Evidence (SDG-CARE) collaboration
por: Lam, Sean Shao Wei, et al.
Publicado: (2023)

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom
por: Mohty, Mohamad, et al.
Publicado: (2020)

The real-world outcomes of multiple myeloma patients treated with daratumumab
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
por: Maignan, Kathleen, et al.
Publicado: (2022)

Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
por: Atrash, Shebli, et al.
Publicado: (2022)

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs
por: Gooding, Sarah, et al.
Publicado: (2015)

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
por: Kim, Christopher, et al.
Publicado: (2018)

Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler(®) Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings
por: Tamási, Lilla, et al.
Publicado: (2022)

1782. Real-World HIV Diagnostic Testing Patterns in the United States
por: Karichu, James, et al.
Publicado: (2019)

Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study: Treatment pattern and outcomes in patients with multiple myeloma
por: He, Jianming, et al.
Publicado: (2020)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study
por: Ishiura, Yoshihisa, et al.
Publicado: (2022)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

Treatment trends in patients with asthma–COPD overlap syndrome in a COPD cohort: findings from a real-world survey
por: Ding, Bo, et al.
Publicado: (2017)

PB2100: REAL-WORLD TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A RETROSPECTIVE CHART STUDY
por: Guillaume, Xavier, et al.
Publicado: (2023)

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
por: Ke, Xuehua, et al.
Publicado: (2018)

P-160: Disparities in multiple myeloma between hispanics and non-hispanics – real world outcomes
por: Shaikh, Hira, et al.
Publicado: (2022)

PB2028: TREATING MULTIPLE MYELOMA IN A RESOURCE-LIMITED SETTING: REAL-WORLD OUTCOMES
por: Martinez, G., et al.
Publicado: (2022)

Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States
por: Medhekar, Rohan, et al.
Publicado: (2022)

Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice
por: Hulin, Cyrille, et al.
Publicado: (2018)

Real World Multiple Myeloma Registry from Jordan, a Developing Country
por: Qasem, Farah, et al.
Publicado: (2022)

P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL-WORLD OBSERVATIONAL CHART REVIEW STUDY
por: Goyal, Ravi K, et al.
Publicado: (2023)

Prevalence, incidence and survival of smoldering multiple myeloma in the United States
por: Ravindran, A, et al.
Publicado: (2016)

Findings of Multiple Myeloma in Afro-Caribbean Patients in the United States
por: Banavali, Ashtami, et al.
Publicado: (2018)

Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States
por: Swami, Umang, et al.
Publicado: (2021)

Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States
por: Mehta, Rutika, et al.
Publicado: (2023)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
por: Hashimoto, Shu, et al.
Publicado: (2023)

P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE
por: Dhakal, B., et al.
Publicado: (2022)

P40 REAL-WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD-LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE
por: Lehne, M., et al.
Publicado: (2023)

Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience
por: Qian, Xifeng, et al.
Publicado: (2018)

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
por: Remes, Kari, et al.
Publicado: (2018)

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma
por: Jagannath, Sundar, et al.
Publicado: (2021)

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
por: Lecat, Catherine S. Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdcajuvqsvb2atatqtlibmcflm